Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DG 5128

Known as: DG-5128 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Intraspinally administered alpha 2-adrenergic agonists are being examined for postoperative analgesia, yet their effects on the… Expand
Is this relevant?
1989
1989
The highly-selective alpha-2 adrenergic agonist dexmedetomidine (D-MED) is capable of inducing muscle flaccidity and anesthesia… Expand
Is this relevant?
1989
1989
1. Electrical transmural stimulation evoked a sympathetic contraction in the isolated dog mesenteric artery. This contraction… Expand
Is this relevant?
1989
1989
The anesthetic-reducing property of medetomidine far exceeds that seen with other alpha 2-adrenergic agonists (e.g., clonidine… Expand
Is this relevant?
1987
1987
Midaglizole (DG-5128), 2-[2-(4,5-dihydro-1H-imidazol-2- yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate, is a novel α2… Expand
Is this relevant?
1987
1987
Midaglizole (DG-5128), 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate, is a new type of… Expand
Is this relevant?
1986
1986
Effects of oral administration of DG-5128, a new oral hypoglycemic agent, on glycemic control after a mixed meal and an in vivo… Expand
Is this relevant?
1983
1983
The effects of a new hypoglycemic agent, DG-5128 (2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride… Expand
Is this relevant?
1982
1982
2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl] pyridine dihydrochloride sesquilhydrate (DG-5128) is a new orally effective… Expand
Is this relevant?
1982
1982
2-[2-(4,5-Dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate (GD-5128) is a new hypoglycemic agent… Expand
Is this relevant?